Sports-inspired Onco-Coaching for Young Adults in Cancer Remission
Official title: REBOND JAS: Feasibility Study of a Sport-Inspired Onco-Coaching Program for Young Adults in Cancer Remission: Rebond-JAs-IPC 2025-017
Run by Institut Paoli-Calmettes · NCT07861971 · Data updated 2026-11-12
We’re testing a sports-style coaching program to support young adults 18–25 who are in cancer remission, to see how many start the coaching and attend the first two sessions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 19 (estimated) |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Marseille) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | August 3, 2028 |
| Study ends | August 3, 2028 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07861971 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 18–25-year-olds in complete remission within one year of cancer treatment who can speak and write French and are treated at Institut Paoli-Calmettes.
✕Probably not a fit
Patients who are currently undergoing treatment (except maintenance) or who are unable to participate in follow-up or remote sessions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, non-randomized feasibility study at Institut Paoli-Calmettes. Twenty-one? actually 19 young adults in complete remission within one year of finishing treatment will be invited to participate. The program uses monthly onco-coaching sessions, offered in person initially and then by phone or video if preferred, with personal goal setting guided by motivational interviewing. Adherence will be measured by the proportion of participants who attend the first two coaching sessions relative to the total enrolled. Coaching aims to help participants establish self-directed strategies for staying engaged in survivorship, with sessions scheduled over 2 to 6 months depending on individual needs.
Why it matters
Potential benefit: If successful, the program could identify a feasible approach to support metastatic? (note: remission) survivorship and improve engagement in post-treatment care for young adults.
How similar studies have gone: Prior work on coaching and motivational interviewing in cancer survivorship has shown promise, but this exact onco-coaching approach in young adults remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female aged 18 to 25 at the time of cancer diagnosis and/or at the time of inclusion. * In complete remission, within one year following the end of treatment and at the time of inclusion. * Treated at the Comprehensive Cancer Center Institut Paoli-Calmettes. * Able to speak and write in French. * Has not objected to participation in the study. * Affiliated with a social security scheme or beneficiary of such a scheme. Non -Inclusion Criteria: * Patient undergoing treatment, except for maintenance therapy. * Patient experiencing a relapse. * Person in an emergency situation, legally protected adult (under guardianship, curatorship, or judicial protection), or unable to express non-opposition. * Patient with clinically confirmed psychological symptoms (e.g., receiving antidepressants, mood stabilizers, anxiolytics, etc.). * Inability to comply with study follow-up due to geographic, social, or psychological reasons. Exclusion Criteria: Relapse occurring between inclusion and the second onco-coaching session.
Where it's running
-
Institut Paoli-Calmettes
Marseille, France Recruiting
Study contacts
- Study coordinator: jihane pakradouni, PhD
- Email: DRCI.UP@ipc.unicancer.fr
- Phone: +33491223778
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating CM369 for advanced solid tumors and blood cancers
This study is testing a new treatment called CM369 to see if it is safe and effective for people with advanced solid tumors and blood cancers.
-
Virtual reality to improve comfort for adults with hematologic cancer in hospital
Researchers are testing whether short VR experiences can help comfort and mood for adults with blood cancers who are staying in the hospital for at least 15 days.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant
This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.
-
Using exercise and nutrition to reduce CAR‑T neurotoxicity in adults with blood cancers
This test will try whether a structured exercise program alone or combined with nutrition advice can lower the risk or severity of neurotoxicity after CAR‑T therapy in adults (18–80) with hematologic cancer.
-
Florida ASCENT Program
This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.